Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PHS:EURO'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 0.67 Max: 2.85
Current: 0.74
During the past 13 years, Euro-Med Laboratories Philippines's highest PB Ratio was 2.85. The lowest was 0.49. And the median was 0.67.
PHS:EURO's PB Ratio is ranked better than 84.8% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs PHS:EURO: 0.74
During the past 12 months, Euro-Med Laboratories Philippines's average Book Value Per Share Growth Rate was 3.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 2.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Euro-Med Laboratories Philippines was 8.20% per year. The lowest was 0.00% per year. And the median was 1.95% per year.
Back to Basics: PB Ratio
Euro-Med Laboratories Philippines (PHS:EURO) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Euro-Med Laboratories Philippines PB Ratio Related Terms
Euro-Med Laboratories Philippines PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's PB Ratio distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's PB Ratio falls into.
Euro-Med Laboratories Philippines PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Euro-Med Laboratories Philippines (PHS:EURO) has a PB Ratio of 0.74 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 10% above median its historical median of 0.67. Over the past decade, Euro-Med Laboratories Philippines' PB Ratio has ranged from 0.49 to 2.85. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #140 out of 921 companies in the Drug Manufacturers industry, placing it in the top 15.2%.
Is Euro-Med Laboratories Philippines' PB Ratio too high?
Euro-Med Laboratories Philippines' current PB Ratio of 0.74 is 10% above median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 2.85. The Drug Manufacturers industry median PB Ratio is 1.90. Euro-Med Laboratories Philippines' value of 0.74 is 61.1% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #140 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #140 out of 921 companies for PB Ratio. This places Euro-Med Laboratories Philippines in the top 15% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.90. Euro-Med Laboratories Philippines' value of 0.74 is 61.1% below this benchmark. Historically, Euro-Med Laboratories Philippines' own PB Ratio has ranged from 0.49 to 2.85 over the past decade. While the company's 10-year median is 0.67 vs. the industry median of 1.90, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current PB Ratio of 0.74 is 61.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current PB Ratio is 0.74, which is 10% above median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.10 — trading 6.8% above its estimated fair value. The current PB Ratio is 0.74, which is 10% above median its 10-year median of 0.67 and 61.1% below the Drug Manufacturers industry median of 1.90. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current PB Ratio is 0.74 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.10 is trading 6.8% above its estimated GF Value™ of ₱1.03.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
PB Ratio: 0.74 (10% above median its 10-year median of 0.67)
GF Value™: ₱1.03 vs. price of ₱1.10 (6.8% above fair value)
Industry Position: 61.1% below the Drug Manufacturers median (#140 of 921)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score
Get the complete analysis for PHS:EURO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
